PROCTER & GAMBLE HEALTH | CIPLA | PROCTER & GAMBLE HEALTH/ CIPLA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.5 | 32.2 | 106.9% | View Chart |
P/BV | x | 10.5 | 5.2 | 203.4% | View Chart |
Dividend Yield | % | 2.0 | 0.6 | 354.9% |
PROCTER & GAMBLE HEALTH CIPLA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
CIPLA Mar-23 |
PROCTER & GAMBLE HEALTH/ CIPLA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,185 | 452.7% | |
Low | Rs | 3,883 | 852 | 455.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 281.9 | 262.8% | |
Earnings per share (Unadj.) | Rs | 138.2 | 35.1 | 393.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 49.7 | 312.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 8.50 | 1,117.6% | |
Avg Dividend yield | % | 2.1 | 0.8 | 246.2% | |
Book value per share (Unadj.) | Rs | 447.6 | 289.2 | 154.8% | |
Shares outstanding (eoy) | m | 16.60 | 807.15 | 2.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 3.6 | 172.8% | |
Avg P/E ratio | x | 33.5 | 29.0 | 115.4% | |
P/CF ratio (eoy) | x | 29.8 | 20.5 | 145.3% | |
Price / Book Value ratio | x | 10.3 | 3.5 | 293.3% | |
Dividend payout | % | 68.7 | 24.2 | 284.0% | |
Avg Mkt Cap | Rs m | 76,761 | 822,164 | 9.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 38,301 | 5.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 227,531 | 5.4% | |
Other income | Rs m | 184 | 5,121 | 3.6% | |
Total revenues | Rs m | 12,480 | 232,653 | 5.4% | |
Gross profit | Rs m | 3,247 | 48,079 | 6.8% | |
Depreciation | Rs m | 281 | 11,721 | 2.4% | |
Interest | Rs m | 8 | 1,095 | 0.7% | |
Profit before tax | Rs m | 3,142 | 40,384 | 7.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 12,029 | 7.0% | |
Profit after tax | Rs m | 2,295 | 28,355 | 8.1% | |
Gross profit margin | % | 26.4 | 21.1 | 125.0% | |
Effective tax rate | % | 27.0 | 29.8 | 90.5% | |
Net profit margin | % | 18.7 | 12.5 | 149.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 168,051 | 7.0% | |
Current liabilities | Rs m | 6,791 | 50,333 | 13.5% | |
Net working cap to sales | % | 40.0 | 51.7 | 77.4% | |
Current ratio | x | 1.7 | 3.3 | 51.7% | |
Inventory Days | Days | 263 | 73 | 358.6% | |
Debtors Days | Days | 343 | 7 | 5,277.6% | |
Net fixed assets | Rs m | 10,617 | 117,318 | 9.0% | |
Share capital | Rs m | 166 | 1,614 | 10.3% | |
"Free" reserves | Rs m | 7,265 | 231,845 | 3.1% | |
Net worth | Rs m | 7,431 | 233,460 | 3.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 290,067 | 7.7% | |
Interest coverage | x | 409.1 | 37.9 | 1,080.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.8 | 70.2% | |
Return on assets | % | 10.3 | 10.2 | 101.6% | |
Return on equity | % | 30.9 | 12.1 | 254.3% | |
Return on capital | % | 42.4 | 17.8 | 238.6% | |
Exports to sales | % | 0 | 22.6 | 0.0% | |
Imports to sales | % | 13.1 | 8.9 | 147.0% | |
Exports (fob) | Rs m | NA | 51,516 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 20,202 | 7.9% | |
Fx inflow | Rs m | 1,465 | 64,282 | 2.3% | |
Fx outflow | Rs m | 1,605 | 20,202 | 7.9% | |
Net fx | Rs m | -140 | 44,080 | -0.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 32,377 | 7.3% | |
From Investments | Rs m | -215 | -23,885 | 0.9% | |
From Financial Activity | Rs m | -985 | -9,583 | 10.3% | |
Net Cashflow | Rs m | 1,160 | -968 | -119.9% |
Indian Promoters | % | 0.0 | 13.4 | - | |
Foreign collaborators | % | 51.8 | 20.0 | 258.6% | |
Indian inst/Mut Fund | % | 20.3 | 50.0 | 40.5% | |
FIIs | % | 7.6 | 25.7 | 29.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 66.5 | 72.4% | |
Shareholders | 56,730 | 425,731 | 13.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Cipla | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.55% | 1.94% | 1.18% |
1-Month | -7.47% | 1.25% | -0.75% |
1-Year | -3.02% | 68.02% | 61.82% |
3-Year CAGR | -9.12% | 22.53% | 18.16% |
5-Year CAGR | 5.75% | 23.24% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Cipla share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Cipla the stake stands at 33.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Cipla.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Cipla.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.